Код: Выделить всё
Welcome to DiscoveryGate Q%^##i R@@@,
DiscoveryGate provides an integrated, indexed, and linked platform for accessing the primary literature, secondary databases, and tertiary reference works. DiscoveryGate will help you make discovery decisions faster.
You have been given a 30 day FREE evaluation with access to all the content offerings available from DiscoveryGate. This is a great opportunity for you to use the applications and use the content that ranges from synthetic chemistry, bioactivity data to pharmacology and patents. You are also able to link to the primary literature sources, use the sophisticated drawing tools and create reports.
To begin using DiscoveryGate go to https://www.discoverygate.com and enter the following information:
User Name: ru!#$4nq@n#@@@163.com
Password: 8@8^_*0
Company ID: q@000%$_
Click "Go Discover".
When you login for the first time, you will be required to change your password. The maximum length of the password is 25 characters. Changing the password ensures your privacy and security.
You will then be directed to download the DiscoveryGate installer, close all Internet browser processes and run the installer. Once the installation has completed your Internet browser will automatically close. The next time you open your Internet browser and login to DiscoveryGate you will have full access to the system. Installation guides are available in the DiscoveryGate software download center and on the Support page.
Support:
You can ask for support directly from the DiscoveryGate support pages, however please note that this evaluation does not provide access to MDL’s Customer Care. DiscoveryGate is a powerful environment and there might be instances where you have questions – please go to the support pages on DiscoveryGate and feel free to issue a request. We will be more than happy to help you.
At the end of the 30 day evaluation, we will ask you to complete a simple survey.
Thank you for evaluating DiscoveryGate!
The DiscoveryGate Team.
Copyright 2002-2005 MDL Information Systems, Inc. ("Elsevier MDL") All rights reserved.
Terms and conditions: https://www.discoverygate.com/iss/terms.jsp
